- Home
- MRVI vs GPAT Comparison
MRVI vs GPAT Comparison
Compare MRVI & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- GPAT
- Stock Information
- Founded
- MRVI 2014
- GPAT 2020
- Country
- MRVI United States
- GPAT United States
- Employees
- MRVI N/A
- GPAT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- GPAT
- Sector
- MRVI Health Care
- GPAT
- Exchange
- MRVI Nasdaq
- GPAT NYSE
- Market Cap
- MRVI 312.4M
- GPAT 365.5M
- IPO Year
- MRVI 2020
- GPAT 2024
- Fundamental
- Price
- MRVI $2.27
- GPAT $10.55
- Analyst Decision
- MRVI Hold
- GPAT
- Analyst Count
- MRVI 10
- GPAT 0
- Target Price
- MRVI $6.84
- GPAT N/A
- AVG Volume (30 Days)
- MRVI 1.6M
- GPAT 153.6K
- Earning Date
- MRVI 08-06-2025
- GPAT 01-01-0001
- Dividend Yield
- MRVI N/A
- GPAT N/A
- EPS Growth
- MRVI N/A
- GPAT N/A
- EPS
- MRVI N/A
- GPAT 0.36
- Revenue
- MRVI $241,856,000.00
- GPAT N/A
- Revenue This Year
- MRVI N/A
- GPAT N/A
- Revenue Next Year
- MRVI $10.62
- GPAT N/A
- P/E Ratio
- MRVI N/A
- GPAT $29.58
- Revenue Growth
- MRVI N/A
- GPAT N/A
- 52 Week Low
- MRVI $1.67
- GPAT $9.98
- 52 Week High
- MRVI $10.03
- GPAT $10.64
- Technical
- Relative Strength Index (RSI)
- MRVI 54.46
- GPAT N/A
- Support Level
- MRVI $2.00
- GPAT N/A
- Resistance Level
- MRVI $2.44
- GPAT N/A
- Average True Range (ATR)
- MRVI 0.15
- GPAT 0.00
- MACD
- MRVI -0.00
- GPAT 0.00
- Stochastic Oscillator
- MRVI 61.36
- GPAT 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.